Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Melphalan”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01983969
What this trial is testing

Aza-SAHA-GBM With AutoSCT for Refractory Lymphoma

Who this might be right for
Advanced CancersLymphoma
M.D. Anderson Cancer Center 61
Not applicableUnknownNCT01572688
What this trial is testing

Safety and Efficacy Study of High Dose Melphalan to Treat Multiple Myeloma

Who this might be right for
Multiple Myeloma
Shandong Lanjin Pharmaceuticals Co.,Ltd 60
Large-scale testing (Phase 3)Ended earlyNCT00644306
What this trial is testing

Comparison of Melphalan-Prednisone (MP) to MP Plus Thalidomide in the Treatment of Newly Diagnosed Very Elderly Patients (> 75 Years) With Multiple Myeloma

Who this might be right for
Newly Diagnosed, Multiple Myeloma
Central Hospital, Nancy, France 232
Testing effectiveness (Phase 2)Study completedNCT01408563
What this trial is testing

Reduced Intensity Double Umbilical Cord Blood Transplantation

Who this might be right for
Non-Hodgkin's LymphomaHodgkin's LymphomaMultiple Myeloma+2 more
Massachusetts General Hospital 33
Testing effectiveness (Phase 2)Ended earlyNCT01875237
What this trial is testing

Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene

Who this might be right for
LeukemiaMyelomaMyeloproliferative Diseases
M.D. Anderson Cancer Center 3
Testing effectiveness (Phase 2)Looking for participantsNCT00920972
What this trial is testing

Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases

Who this might be right for
Metabolic DisordersHematologic, Immune, or Bone Marrow DisordersHemoglobinopathies+1 more
Washington University School of Medicine 220
Large-scale testing (Phase 3)Study completedNCT00405756
What this trial is testing

Compare MPR With MP in Newly Diagnosed Multiple Myeloma Subjects 65 Years Old or Older.

Who this might be right for
Newly Diagnosed Multiple Myeloma
Celgene Corporation 459
Testing effectiveness (Phase 2)Study completedNCT00003402
What this trial is testing

Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphoma
University of Maryland, Baltimore 35
Large-scale testing (Phase 3)Study completedNCT00232934
What this trial is testing

Melphalan, Prednisone and Thalidomide Versus Melphalan and Prednisone in Elderly Myeloma Patients

Who this might be right for
Multiple Myeloma
Gruppo Italiano per lo Studio del Mieloma Multiplo 400
Testing effectiveness (Phase 2)UnknownNCT01665014
What this trial is testing

Total Marrow Irradiation and High-dose Melphalan for Double Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice 50
Post-approval studies (Phase 4)Study completedNCT00352703
What this trial is testing

PROMPT - Palifermin in Reduction of Oral Mucositis in PBSC Transplantation

Who this might be right for
Non-Hodgkin's LymphomaMultiple Myeloma
Swedish Orphan Biovitrum 145
Testing effectiveness (Phase 2)Ended earlyNCT02589145
What this trial is testing

Lenalidomide Combined With Vorinostat/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Diffuse Large B-Cell Lymphoma of the ABC Subtype

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 8
Early research (Phase 1)Ended earlyNCT00800150
What this trial is testing

Total Marrow and Total Lymph Node Irradiation, Fludarabine, and Melphalan Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Hematological Cancer That Has Not Responded to Treatment

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+3 more
City of Hope Medical Center 6
Testing effectiveness (Phase 2)Study completedNCT00357396
What this trial is testing

Busulfan, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk Ewing's Tumors

Who this might be right for
Sarcoma
Memorial Sloan Kettering Cancer Center 10
Testing effectiveness (Phase 2)Study completedNCT00003199
What this trial is testing

Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer

Who this might be right for
Estrogen Receptor-negative Breast CancerEstrogen Receptor-positive Breast CancerInflammatory Breast Cancer+5 more
Fred Hutchinson Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT00313625
What this trial is testing

Melphalan and Busulfan Followed By Donor Peripheral Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Fred Hutchinson Cancer Center 20
Early research (Phase 1)Study completedNCT00392691
What this trial is testing

Melphalan, Yttrium Y 90 Ibritumomab Tiuxetan, and Rituximab Followed by Autologous Stem Cell Transplant in Treating Older Patients With Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment

Who this might be right for
Lymphoma
Swiss Cancer Institute 20
Testing effectiveness (Phase 2)Study completedNCT01729091
What this trial is testing

Umbilical Cord Blood-Derived Natural Killer Cells, Elotuzumab, Lenalidomide, and High Dose Melphalan, Followed by Stem Cell Transplant in Treating Patients With Multiple Myeloma

Who this might be right for
Plasma Cell LeukemiaPlasma Cell Myeloma
M.D. Anderson Cancer Center 72
Early research (Phase 1)Ended earlyNCT01182233
What this trial is testing

Total Skeletal Irradiation in Multiple Myeloma Before Second Autologous Hematopoietic Stem Cell Transplantation

Who this might be right for
Multiple Myeloma
University of Rochester 4
Large-scale testing (Phase 3)Study completedNCT01277016
What this trial is testing

A Trial for Systemic Light-chain (AL) Amyloidosis

Who this might be right for
AL Amyloidosis
European Myeloma Network B.V. 110
Next Page